10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
ELI LILLY & CO | |||
Ticker: LLY Fiscal Year: 2015 | |||
Consolidated Statements of Operations | |||
Period Ending Dec 31, 2015 10-K (Filed: Feb 19, 2016) | |||
| (In Thousands) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | |
| Revenue | $ 19,958,700 | 19,615,600 | 23,113,100 |
| Cost of sales | 5,037,200 | 4,932,500 | 4,908,100 |
| Research and development | 4,796,400 | 4,733,600 | 5,531,300 |
| Marketing, selling, and administrative | 6,533,000 | 6,620,800 | 7,125,600 |
| Acquired in-process research and development | 535,000 | 200,200 | 57,100 |
| Asset impairment, restructuring, and other special charges | 367,700 | 468,700 | 120,600 |
| Other-net, (income) expense | (100,600) | (340,500) | (518,900) |
| Cost of sales, operating expenses, and other-net | 17,168,700 | 16,615,300 | 17,223,800 |
| Income before income taxes | 2,790,000 | 3,000,300 | 5,889,300 |
| Income taxes | 381,600 | 609,800 | 1,204,500 |
| Net income | 2,408,400 | 2,390,500 | 4,684,800 |
| Earnings Per Share: | |||
| Basic | 2.27 | 2.23 | 4.33 |
| Diluted | 2.26 | 2.23 | 4.32 |
| Shares used in calculation of earnings per share: | |||
| Basic | 1,061,913 | 1,069,932 | 1,080,874 |
| Diluted | 1,065,720 | 1,074,286 | 1,084,766 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
ELI LILLY & CO | |||
Ticker: LLY Fiscal Year: 2015 | |||
Consolidated Statements of Comprehensive Income (Loss) | |||
Period Ending Dec 31, 2015 10-K (Filed: Feb 19, 2016) | |||
| (In Thousands, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | |
| Net income | $ 2,408,400 | 2,390,500 | 4,684,800 |
| Other comprehensive income (loss) | |||
| Change in foreign currency translation gains (losses) | (859,800) | (961,400) | 36,200 |
| Change in net unrealized gains and losses on securities | (138,100) | (162,200) | 204,300 |
| Change in defined benefit pension and retiree health benefit plans | 572,900 | (1,327,600) | 2,592,200 |
| Change in effective portion of cash flow hedges | (42,000) | (14,500) | (123,800) |
| Other comprehensive income (loss) before income taxes | (467,000) | (2,465,700) | 2,708,900 |
| Provision for income taxes related to other comprehensive income (loss) items | (121,900) | 476,600 | (914,500) |
| Other comprehensive income (loss) | (588,900) | (1,989,100) | 1,794,400 |
| Comprehensive income | 1,819,500 | 401,400 | 6,479,200 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
ELI LILLY & CO | |||
Ticker: LLY Fiscal Year: 2015 | |||
Consolidated Statements of Cash Flows | |||
Period Ending Dec 31, 2015 10-K (Filed: Feb 19, 2016) | |||
| (In Thousands, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | |
| Cash and Cash Equivalents, Period Increase (Decrease) [Abstract] | |||
| Net Cash Provided by Operating Activities [Abstract] | |||
| Cash Flows from Operating Activities | |||
| Net income | $ 2,408,400 | 2,390,500 | 4,684,800 |
| Adjustments to Reconcile Net Income to Cash Flows from Operating Activities: | |||
| Depreciation and amortization | 1,427,700 | 1,379,000 | 1,445,600 |
| Change in deferred income taxes | (748,400) | 36,800 | 265,900 |
| Stock-based compensation expense | 217,800 | 156,000 | 144,900 |
| Acquired in-process research and development | 535,000 | 200,200 | 57,100 |
| Income related to termination of the exenatide collaboration with Amylin | 0 | 0 | (495,400) |
| Net proceeds from (payments for) terminations of interest rate swaps | (186,100) | 340,700 | 0 |
| Other non-cash operating activities, net | 36,400 | 13,800 | 25,100 |
| Other changes in operating assets and liabilities, net of acquisitions and divestitures: | |||
| Receivables - (increase) decrease | (304,500) | 117,400 | (152,700) |
| Inventories - (increase) decrease | (736,300) | (307,100) | (286,500) |
| Other assets - (increase) decrease | (338,800) | 411,500 | 116,500 |
| Accounts payable and other liabilties-increase (decrease) | 461,600 | (371,700) | (70,300) |
| Net Cash Provided by Operating Activities | 2,772,800 | 4,367,100 | 5,735,000 |
| Net Cash Provided By (Used In) Investing Activities [Abstract] | |||
| Cash Flows from Investing Activities | |||
| Purchases of property and equipment | (1,066,200) | (1,162,600) | (1,012,100) |
| Disposals of property and equipment | 92,600 | 15,300 | 179,400 |
| Cash released (restricted) for pending acquisition | 5,405,600 | (5,405,600) | 0 |
| Proceeds from sales and maturities of short-term investments | 2,161,800 | 4,054,100 | 3,320,100 |
| Purchases of short-term investments | (842,200) | (1,637,800) | (1,531,000) |
| Proceeds from sales of noncurrent investments | 3,068,400 | 11,009,400 | 11,235,000 |
| Purchases of noncurrent investments | (3,226,500) | (9,802,700) | (14,041,900) |
| Proceeds from sale of product rights | 410,000 | 0 | 0 |
| Purchase of product rights | 0 | (308,300) | (24,100) |
| Purchases of in-process research and development | (560,000) | (95,000) | (57,100) |
| Cash paid for acquisitions, net of cash acquired | (5,283,100) | (551,400) | (43,700) |
| Other investing activities, net | (133,600) | (24,500) | (97,400) |
| Net Cash Provided by (Used for) Investing Activities | 26,800 | (3,909,100) | (2,072,800) |
| Net Cash Used in Financing Activities [Abstract] | |||
| Cash Flows from Financing Activities | |||
| Dividends paid | (2,127,300) | (2,101,200) | (2,120,700) |
| Net change in short-term borrowings | (2,680,600) | 2,680,600 | 0 |
| Proceeds from issuance of long-term debt | 4,454,700 | 992,900 | 0 |
| Repayments of long-term debt | (1,955,700) | (1,034,800) | (10,500) |
| Purchases of common stock | (749,500) | (800,000) | (1,698,100) |
| Other financing activities, net | 139,200 | 187,400 | 0 |
| Net Cash Used for Financing Activities | (2,919,200) | (75,100) | (3,829,300) |
| Effect of exchange rate changes on cash and cash equivalents | (85,600) | (341,500) | (21,500) |
| Net increase (decrease) in cash and cash equivalents | (205,200) | 41,400 | (188,600) |
| Cash and cash equivalents at beginning of year | 3,871,600 | 3,830,200 | |
| Cash and Cash Equivalents at End of Year | 3,666,400 | 3,871,600 | 3,830,200 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
ELI LILLY & CO | ||
Ticker: LLY Fiscal Year: 2015 | ||
Consolidated Balance Sheets | ||
Period Ending Dec 31, 2015 10-K (Filed: Feb 19, 2016) | ||
| (In Thousands, except shares in actual) | ||
| As of | As of | |
| Dec 31, 2015 | Dec 31, 2014 | |
| Assets Abstract | ||
| Current Assets | ||
| Cash and cash equivalents | $ 3,666,400 | 3,871,600 |
| Short-term investments | 785,400 | 955,400 |
| Accounts receivable, net of allowances of $44.3 (2015) and $55.0 (2014) | 3,513,000 | 3,234,600 |
| Other receivables | 558,600 | 566,700 |
| Inventories | 3,445,800 | 2,740,000 |
| Prepaid expenses and other | 604,400 | 560,000 |
| Total current assets | 12,573,600 | 11,928,300 |
| Other Assets | ||
| Restricted cash | 0 | 5,405,600 |
| Investments | 3,646,600 | 4,568,900 |
| Goodwill | 4,039,900 | 1,758,100 |
| Other intangibles, net | 5,034,800 | 2,884,200 |
| Sundry | 2,220,500 | 1,798,600 |
| Total other assets | 14,941,800 | 16,415,400 |
| Property and equipment, net | 8,053,500 | 7,963,900 |
| Total assets | 35,568,900 | 36,307,600 |
| Liabilities and Shareholders' Equity | ||
| Current Liabilities | ||
| Short-term borrowings and current maturities of long-term debt | 6,100 | 2,688,700 |
| Accounts payable | 1,338,200 | 1,128,100 |
| Employee compensation | 967,000 | 759,000 |
| Sales rebates and discounts | 2,560,100 | 2,068,800 |
| Dividends payable | 539,000 | 530,300 |
| Income taxes payable | 358,900 | 93,500 |
| Other current liabilities | 2,460,300 | 2,472,600 |
| Total current liabilities | 8,229,600 | 9,741,000 |
| Other Liabilities | ||
| Long-term debt | 7,972,400 | 5,332,800 |
| Accrued retirement benefits | 2,160,300 | 2,562,900 |
| Long-term income taxes payable | 868,900 | 998,500 |
| Other noncurrent liabilities | 1,747,400 | 2,284,300 |
| Total other liabilities | 12,749,000 | 11,178,500 |
| Eli Lilly and Company Shareholders' Equity | ||
| Common stock | 691,300 | 694,600 |
| Additional paid-in capital | 5,552,100 | 5,292,300 |
| Retained earnings | 16,011,800 | 16,482,700 |
| Employee benefit trust | (3,013,200) | (3,013,200) |
| Accumulated other comprehensive loss | (4,580,700) | (3,991,800) |
| Cost of common stock in treasury | (90,000) | (91,400) |
| Total Eli Lilly and Company shareholders' equity | 14,571,300 | 15,373,200 |
| Noncontrolling interests | 19,000 | 14,900 |
| Total equity | 14,590,300 | 15,388,100 |
| Total liabilities and equity | 35,568,900 | 36,307,600 |
| External Links | |
| ELI LILLY & CO (LLY) Fiscal Year 2015 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |